🇺🇸 FDA
Patent

US 7638130

Truncated recombinant major outer membrane protein antigen (R56) of Orientia tsutsugamushi strains Karp, Kato and Gilliam and its use in antibody based detection assays and vaccines

granted A61KA61K2039/53A61K39/00

Quick answer

US patent 7638130 (Truncated recombinant major outer membrane protein antigen (R56) of Orientia tsutsugamushi strains Karp, Kato and Gilliam and its use in antibody based detection assays and vaccines) held by United States of America as represented by the Secretary of the Air Force expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K2039/53, A61K39/00, A61P, A61P33/00